(Q47758845)

English

Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

human subject research project

0 references

1 reference

based on heuristic

inferred from title

author name string

Hong SS

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Lee SH

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Lee YJ

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Chung SJ

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Lee MH

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Shim CK

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Journal of Controlled Release

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

51

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

2-3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

185-192

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900167-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of efficacy, secondary failure rate, and complications of sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900167-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of gliclazide in serum by high-performance liquid chromatography using solid-phase extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900167-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The mode of action and clinical pharmacology of gliclazide: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900167-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-3659(97)00167-3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9685916

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47758845&oldid=2169977996"